Fig. 3: High 4EBP1 protein expression is associated with unfavorable prognosis of MB patients.

A, B Representative images of negative (A) and positive (B) 4EBP1 immunohistochemical staining of selected MB samples represented on the MBs TMA. C–F Kaplan–Meier survival estimates of overall survival (C, E) or progression free-survival (D, F) of MB patients stratified by their 4EBP1 staining score in all patients (C, D) or in Group 3 and Group 4 combined (E, F).